KalVista Pharmaceuticals Earning Date (KALV)

USA |NASDAQ |USD

KALV Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Dec 8, 2021 Oct 2021 $-0.79 $-0.66 $-0.58
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Dec 8, 2021 Oct 2021 $0.00 $0.00 $0.00

Kalvista Pharmaceuticals's next earnings date is Wednesday, Dec 8, 2021 for the fiscal quarter ending Oct 2021.

KALV Earnings Date & History Chart

KALV Earnings & Revenue Forecast

KALV Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jan 2022 7 $-0.85 $-1.05 $-0.75
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2022 7 $-3.20 $-3.82 $-2.49
Apr 2023 7 $-3.66 $-4.34 $-2.61

KALV Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jan 2022 0 / 0 $-0.85 $-0.81 $-0.81
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Apr 2022 0 / 0 $-3.20 $-3.19 $-3.19
Apr 2023 0 / 0 $-3.66 $-3.52 $-3.52

KALV Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jan 2022 7 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Apr 2022 7 $0.00 $0.00 $0.00
Apr 2023 7 $10.90M $0.00 $30.00M

KALV Earnings Date & Revenue History

KALV Earnings History

|
Show More
Show More

KALV Revenue History

|
Show More
Show More

Kalvista Pharmaceuticals Next Earnings Date & Report

KALV Next Earnings Date & Report Preview: Oct 2021 (FQ)

KALV's next earnings date is Wednesday, Dec 8, 2021 for the fiscal quarter ending Oct 31, 2021.

According to 7 analysts, the average EPS estimation for Kalvista Pharmaceuticals's next quarterly earnings is $-0.79, with a low EPS estimation of $-0.92, and a high estimation of $-0.71.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.79, the last 2 month trend is $-0.76, and the 3 month trend is $-0.76.

Based on 6 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Kalvista Pharmaceuticals Previous Earnings Dates & Reports

KALV Previous Earnings Date & Report Recap: Jul 2021 (FQ)

Kalvista Pharmaceuticals's previous earnings date was Sep 9, 2021 for its fiscal quarter ended Jul 31, 2021.

KALV's earnings per share (EPS) was $-0.66, beating the consensus analysts forecast of $-0.72 by 8.65%.

The EPS was higher than the previous fiscal quarter (Apr 2021) by -1.49%, and lower than the same period a year before (Jul 2020) by 8.20%.

Revenues were $0.00.

The company reported a net income of $-16.11M.

Free cash flow for the quarter was $-18.02M , compared to $-11.08M last quarter and $-3.61M a year before.

KALV ended the quarter with $7.38M in total debt, an increase of 24.88% compared to the previous quarter, and an increase of 384.50% compared to the same quarter a year before.

KALV Previous Earnings Date & Report Recap: Apr 2021 (FY)

Kalvista Pharmaceuticals's previous annual earnings date was Jul 13, 2021 for its fiscal year ended Apr 30, 2021.

KALV's earnings per share (EPS) was $-2.42, missing the consensus analysts forecast of $-2.30 by 5.22% , and lower than the previous year's EPS (Apr 2020) by 47.56%.

Revenues were $0.00.

The company reported a net income of $-46.24M.

Kalvista Pharmaceuticals reported a free cash flow of $-30.25M for its fiscal year, compared to $-45.04M a year ago.

The company ended the fiscal year with $5.91M in total debt, an increase of 259.21% compared to the previous year.